A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts [BGs] reduces the excretion of E. coli O157:H7 in calves
Cattle are the main reservoir of enterohemorrhagic . Escherichia coli O157:H7, a bacterium that, in humans, causes hemorrhagic colitis and hemolytic uremic syndrome [HUS], a life-threatening disease, especially in children and older people. Therefore, the development of vaccines preventing colonizat...
Otros Autores: | , , , , , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | Inglés |
Materias: | |
Acceso en línea: | http://ri.agro.uba.ar/files/intranet/articulo/2012Vilte.pdf LINK AL EDITOR |
Aporte de: | Registro referencial: Solicitar el recurso aquí |
LEADER | 09475nab a22021017a 4500 | ||
---|---|---|---|
001 | AR-BaUFA000218 | ||
003 | AR-BaUFA | ||
005 | 20220318104308.0 | ||
008 | 181208t2012 |||||o|||||00||||eng d | ||
999 | |c 46652 |d 46652 | ||
022 | |a 0165-2427 | ||
024 | |a 10.1016/j.vetimm.2012.03.002 | ||
040 | |a AR-BaUFA |c AR-BaUFA | ||
245 | 1 | 0 | |a A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts [BGs] reduces the excretion of E. coli O157:H7 in calves |
520 | |a Cattle are the main reservoir of enterohemorrhagic . Escherichia coli O157:H7, a bacterium that, in humans, causes hemorrhagic colitis and hemolytic uremic syndrome [HUS], a life-threatening disease, especially in children and older people. Therefore, the development of vaccines preventing colonization of cattle by . E. coli O157:H7 could be a main tool for an HUS control program. In the present study, we evaluated bacterial ghosts [BGs] of . E. coli O157:H7 as an experimental vaccine against this pathogen. BGs are empty envelopes of Gram-negative bacteria, which retain the morphological surface make-up of their living counterparts and are produced by controlled expression of the cloned protein E, which causes loss of all the cytoplasm content. In this work, . E. coli O157:H7 BGs were used for subcutaneous immunization of calves. The vaccinated animals elicited significant levels of BG-specific IgG but not IgA antibodies in serum. Low levels of IgA and IgG antibodies against BGs were detected in saliva from vaccinated animals. Following oral challenge with . E. coli O157:H7, a significant reduction in both the duration and total bacterial shedding was observed in vaccinated calves compared to the nonimmunized group. We demonstrated that systemic vaccination with . E. coli O157 BGs provides protection in a bovine experimental model. Further research is needed to reach a higher mucosal immune response leading to an optimal vaccine. | ||
653 | 0 | |a BACTERIAL GHOSTS | |
653 | 0 | |a CATTLE | |
653 | 0 | |a E. COLI O157:H7 | |
653 | 0 | |a VACCINE | |
653 | 0 | |a BACTERIAL VACCINE | |
653 | 0 | |a IMMUNOGLOBULIN A | |
653 | 0 | |a IMMUNOGLOBULIN G | |
653 | 0 | |a ANIMAL EXPERIMENT | |
653 | 0 | |a ANIMAL TISSUE | |
653 | 0 | |a BACTERIAL COLONIZATION | |
653 | 0 | |a BACTERIAL GHOST | |
653 | 0 | |a CONTROLLED STUDY | |
653 | 0 | |a CYTOPLASM | |
653 | 0 | |a ESCHERICHIA COLI | |
653 | 0 | |a HUMORAL IMMUNITY | |
653 | 0 | |a IMMUNIZATION | |
653 | 0 | |a IMMUNOGLOBULIN BLOOD LEVEL | |
653 | 0 | |a MALE | |
653 | 0 | |a NONHUMAN | |
653 | 0 | |a PROTEIN EXPRESSION | |
653 | 0 | |a SALIVA ANALYSIS | |
653 | 0 | |a VACCINATION | |
653 | 0 | |a WESTERN BLOTTING | |
653 | 0 | |a ANIMALS | |
653 | 0 | |a ANTIBODIES, BACTERIAL | |
653 | 0 | |a BACTERIAL SHEDDING | |
653 | 0 | |a CATTLE DISEASES | |
653 | 0 | |a ENZYME-LINKED IMMUNOSORBENT ASSAY | |
653 | 0 | |a ESCHERICHIA COLI INFECTIONS | |
653 | 0 | |a ESCHERICHIA COLI O157 | |
653 | 0 | |a ESCHERICHIA COLI VACCINES | |
653 | 0 | |a RANDOM ALLOCATION | |
653 | 0 | |a ANIMALIA | |
653 | 0 | |a BACTERIA [MICROORGANISMS] | |
653 | 0 | |a BOS | |
653 | 0 | |a BOVINAE | |
653 | 0 | |a NEGIBACTERIA | |
700 | 1 | |9 70008 |a Vilte, Daniel A. | |
700 | 1 | |9 70009 |a Larzábal, Mariano | |
700 | 1 | |a Mayr, U. B. |9 70010 | |
700 | 1 | |9 44669 |a Garbaccio, Sergio | |
700 | 1 | |9 70011 |a Gammella, Mariela | |
700 | 1 | |9 70012 |a Rabinovitz, Bettina C. | |
700 | 1 | |9 69467 |a Delgado, Fernando | |
700 | 1 | |9 48057 |a Meikle, Virginia | |
700 | 1 | |9 12817 |a Cantet, Rodolfo Juan Carlos | |
700 | 1 | |a Lubitz, P. |9 70013 | |
700 | 1 | |a Lubitz, W. |9 70014 | |
700 | 1 | |9 38812 |a Cataldi, Angel Adrián | |
700 | 1 | |9 70015 |a Mercado, Elsa C. | |
773 | |t Veterinary Immunology and Immunopathology |g Vol.146, no.2 (2012), p.169-176 | ||
856 | |u http://ri.agro.uba.ar/files/intranet/articulo/2012Vilte.pdf |i En reservorio |q application/pdf |f 2012Vilte |x MIGRADOS2018 | ||
856 | |u http://www.elsevier.com/ |x MIGRADOS2018 |z LINK AL EDITOR | ||
900 | |a as | ||
900 | |a 20131220 | ||
900 | |a N | ||
900 | |a SCOPUS | ||
900 | |a a | ||
900 | |a s | ||
900 | |a ARTICULO | ||
900 | |a EN LINEA | ||
900 | |a 01652427 | ||
900 | |a 10.1016/j.vetimm.2012.03.002 | ||
900 | |a ^tA systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts [BGs] reduces the excretion of E. coli O157:H7 in calves | ||
900 | |a ^aVilte^bD.A. | ||
900 | |a ^aLarzábal^bM. | ||
900 | |a ^aMayr^bU.B. | ||
900 | |a ^aGarbaccio^bS. | ||
900 | |a ^aGammella^bM. | ||
900 | |a ^aRabinovitz^bB.C. | ||
900 | |a ^aDelgado^bF. | ||
900 | |a ^aMeikle^bV. | ||
900 | |a ^aCantet^bR.J.C. | ||
900 | |a ^aLubitz^bP. | ||
900 | |a ^aLubitz^bW. | ||
900 | |a ^aCataldi^bA. | ||
900 | |a ^aMercado^bE.C. | ||
900 | |a ^aVilte^bD. A. | ||
900 | |a ^aLarzábal^bM. | ||
900 | |a ^aMayr^bU. B. | ||
900 | |a ^aGarbaccio^bS. | ||
900 | |a ^aGammella^bM. | ||
900 | |a ^aRabinovitz^bB. C. | ||
900 | |a ^aDelgado^bF. | ||
900 | |a ^aMeikle^bV. | ||
900 | |a ^aCantet^bR. J. C. | ||
900 | |a ^aLubitz^bP. | ||
900 | |a ^aLubitz^bW. | ||
900 | |a ^aCataldi^bA. A. | ||
900 | |a ^aMercado^bE. C. | ||
900 | |a ^aVilte^bD.A.^tInstituto de PatobiologÃa, Instituto Nacional de TecnologÃa Agropecuaria [INTA], Nicolás Repetto y De los Reseros, 1686 Hurlingham, Argentina | ||
900 | |a ^aLarzábal^bM.^tInstituto de BiotecnologÃa, Instituto Nacional de TecnologÃa Agropecuaria [INTA], Nicolás Repetto y De los Reseros, 1686 Hurlingham, Argentina | ||
900 | |a ^aMayr^bU.B.^tBIRD-C GmbH and CoKEG, Haupstrasse 88, 3420 Kritzendorf, Austria | ||
900 | |a ^aGarbaccio^bS.^tDepartamento de Producción Animal, Facultad de AgronomÃa, Universidad de Buenos Aires - CONICET, Av. San MartÃn 4453, 1417 Buenos Aires, Argentina | ||
900 | |a ^aGammella^bM. | ||
900 | |a ^aRabinovitz^bB.C. | ||
900 | |a ^aDelgado^bF. | ||
900 | |a ^aMeikle^bV. | ||
900 | |a ^aCantet^bR.J.C. | ||
900 | |a ^aLubitz^bP. | ||
900 | |a ^aLubitz^bW. | ||
900 | |a ^aCataldi^bA. | ||
900 | |a ^aMercado^bE.C. | ||
900 | |a ^tVeterinary Immunology and Immunopathology^cVet. Immunol. Immunopathol. | ||
900 | |a en | ||
900 | |a 169 | ||
900 | |a ^i | ||
900 | |a Vol. 146, no. 2 | ||
900 | |a 176 | ||
900 | |a BACTERIAL GHOSTS | ||
900 | |a CATTLE | ||
900 | |a E. COLI O157:H7 | ||
900 | |a VACCINE | ||
900 | |a BACTERIAL VACCINE | ||
900 | |a IMMUNOGLOBULIN A | ||
900 | |a IMMUNOGLOBULIN G | ||
900 | |a ANIMAL EXPERIMENT | ||
900 | |a ANIMAL TISSUE | ||
900 | |a BACTERIAL COLONIZATION | ||
900 | |a BACTERIAL GHOST | ||
900 | |a CONTROLLED STUDY | ||
900 | |a CYTOPLASM | ||
900 | |a ESCHERICHIA COLI | ||
900 | |a HUMORAL IMMUNITY | ||
900 | |a IMMUNIZATION | ||
900 | |a IMMUNOGLOBULIN BLOOD LEVEL | ||
900 | |a MALE | ||
900 | |a NONHUMAN | ||
900 | |a PROTEIN EXPRESSION | ||
900 | |a SALIVA ANALYSIS | ||
900 | |a VACCINATION | ||
900 | |a WESTERN BLOTTING | ||
900 | |a ANIMALS | ||
900 | |a ANTIBODIES, BACTERIAL | ||
900 | |a BACTERIAL SHEDDING | ||
900 | |a CATTLE DISEASES | ||
900 | |a ENZYME-LINKED IMMUNOSORBENT ASSAY | ||
900 | |a ESCHERICHIA COLI INFECTIONS | ||
900 | |a ESCHERICHIA COLI O157 | ||
900 | |a ESCHERICHIA COLI VACCINES | ||
900 | |a RANDOM ALLOCATION | ||
900 | |a ANIMALIA | ||
900 | |a BACTERIA [MICROORGANISMS] | ||
900 | |a BOS | ||
900 | |a BOVINAE | ||
900 | |a NEGIBACTERIA | ||
900 | |a Cattle are the main reservoir of enterohemorrhagic . Escherichia coli O157:H7, a bacterium that, in humans, causes hemorrhagic colitis and hemolytic uremic syndrome [HUS], a life-threatening disease, especially in children and older people. Therefore, the development of vaccines preventing colonization of cattle by . E. coli O157:H7 could be a main tool for an HUS control program. In the present study, we evaluated bacterial ghosts [BGs] of . E. coli O157:H7 as an experimental vaccine against this pathogen. BGs are empty envelopes of Gram-negative bacteria, which retain the morphological surface make-up of their living counterparts and are produced by controlled expression of the cloned protein E, which causes loss of all the cytoplasm content. In this work, . E. coli O157:H7 BGs were used for subcutaneous immunization of calves. The vaccinated animals elicited significant levels of BG-specific IgG but not IgA antibodies in serum. Low levels of IgA and IgG antibodies against BGs were detected in saliva from vaccinated animals. Following oral challenge with . E. coli O157:H7, a significant reduction in both the duration and total bacterial shedding was observed in vaccinated calves compared to the nonimmunized group. We demonstrated that systemic vaccination with . E. coli O157 BGs provides protection in a bovine experimental model. Further research is needed to reach a higher mucosal immune response leading to an optimal vaccine. | ||
900 | |a 146 | ||
900 | |a 2 | ||
900 | |a 2012 | ||
900 | |a ^cH | ||
900 | |a AAG | ||
900 | |a AGROVOC | ||
900 | |a 2012Vilte | ||
900 | |a AAG | ||
900 | |a http://ri.agro.uba.ar/files/intranet/articulo/2012Vilte.pdf | ||
900 | |a 2012Vilte.pdf | ||
900 | |a http://www.elsevier.com/ | ||
900 | |a http://www.scopus.com/inward/record.url?eid=2-s2.0-84859512760&partnerID=40&md5=038048a3836f13efc30c3f8f3f0126e3 | ||
900 | |a ^a^b^c^d^e^f^g^h^i | ||
900 | |a OS | ||
942 | 0 | 0 | |c ARTICULO |2 udc |
942 | 0 | 0 | |c ENLINEA |2 udc |